Literature DB >> 15167043

Human papillomavirus infection in the etiology of laryngeal carcinoma.

Christopher G L Hobbs1, Martin A Birchall.   

Abstract

PURPOSE OF REVIEW: One fifth of cancers worldwide are associated with viral infection. Indeed, the causal link between human papillomavirus and cervical carcinoma is so well established that it is thought to be the first necessary cause of human cancer ever identified. One of the primary aims of research in this area is to reduce cancer prevalence by vaccination. However, the role that human papillomavirus plays in carcinogenesis of the head and neck region may also have important implications for its prevention and treatment. RECENT
FINDINGS: Although human papillomavirus was first identified in the larynx 20 years ago, the extent to which it is present in epithelium of the normal population is unclear. Laryngeal papillomas are the most common benign tumors in the larynx. They are associated with a small risk (3 to 7%) of malignant transformation, in which smoking and irradiation appear to be cofactors. The search for alternate risk factors for the development of laryngeal cancer, particularly in those who are nonsmokers and nondrinkers, has led to the hypothesis that human papillomavirus may have a pivotal role. Epidemiologic studies, although not conclusive, strongly suggest its involvement in the etiology of a subset of laryngeal carcinomas. Recent molecular evidence supports this.
SUMMARY: An adequately powered, multicenter case-control study is required to elucidate the full extent of this association and to examine the relation between the virus and other risk factors.

Entities:  

Mesh:

Year:  2004        PMID: 15167043     DOI: 10.1097/00020840-200404000-00006

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  Multifocal Presentation of a Laryngeal Disorder.

Authors:  T K Prakash; S Abhilash; G Rajeshwari; H Sundararaju
Journal:  J Clin Diagn Res       Date:  2017-07-01

2.  Role of human papillomavirus in the development of urothelial carcinoma.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Ahmet Bilici; Dilek Sakirahmet
Journal:  Med Oncol       Date:  2010-04-29       Impact factor: 3.064

3.  Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels.

Authors:  Virgilijus Uloza; Vykintas Liutkevičius; Dalia Pangonytė; Viktoras Saferis; Vaiva Lesauskaitė
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-01-23       Impact factor: 2.503

4.  Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Resat Dabak; Oya Uygur Bayramicli
Journal:  Med Oncol       Date:  2010-01-16       Impact factor: 3.064

Review 5.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Authors:  Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

6.  Frequency of Human Papillomavirus (HPV) 16 and 18 Detectionzzm321990in Paraffin- Embedded Laryngeal Carcinoma Tissue

Authors:  Seyed Zinab Hosseini; Manoochehr Makvandi; Alireza Samarbafzade; Ali Timori; Nastaran Ranjbar; Nader Saki; Nilofar Nisi; Toran Shahani; Mehran Varnaseri; Kambiz Angali Ahmadi
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

7.  Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Authors:  Turid Omland; Kathrine A Lie; Harriet Akre; Lars Erik Sandlie; Peter Jebsen; Leiv Sandvik; Dag Andre Nymoen; Davit Bzhalava; Joakim Dillner; Kjell Brøndbo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

8.  Identification of key target genes and pathways in laryngeal carcinoma.

Authors:  Feng Liu; Jintao Du; Jun Liu; Bei Wen
Journal:  Oncol Lett       Date:  2016-06-17       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.